23 August 2024
Malaysia is expected to access long-acting cabotegravir (CAB-LA) by March 2025, offering a more reliable HIV prevention option than daily PrEP pills. CAB-LA only needs an injection every 8 weeks, after an initial 2 injections 4 weeks apart.